InflaRx N.V.
IFRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001708688
No open-market purchases or sales by InflaRx N.V. insiders were filed in the last 90 days; 62 institutions reported holding it in 13F filings for Q2 2026, worth $211.6M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding InflaRx N.V. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 37 | 1 | 35 | −1 |
| Shares | 11.2M | 174.2K | 8.88M | −2.11M (−19.2%) |
| Value | $33.1M | $517.0K | $23.0M | −$9.64M (−29.5%) |
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (6)
Institutions that held InflaRx N.V. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 26,016 | $67.0K | 0.01% |
| Two Sigma Securities, LLC | 22,553 | $58.0K | 0.01% |
| Geode Capital Management, LLC | 18,991 | $49.0K | 0.00% |
| Two Sigma Investments, LP | 11,070 | $29.0K | 0.00% |
| JPMorgan Chase & Co | 609 | $2.00K | 0.00% |
| Royal Bank of Canada | 776 | $2.00K | 0.00% |
Sold out (7)
Institutions that held InflaRx N.V. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Altium Capital Management LP | 161,206 | $479.0K |
| Verition Fund Management LLC | 85,761 | $255.0K |
| Commonwealth of Pennsylvania Public School Empls Retrmt Sys | 49,800 | $148.0K |
| Gsa Capital Partners LLP | 46,633 | $139.0K |
| Algert Global LLC | 23,010 | $68.0K |
| Personal Cfo Solutions, LLC | 11,000 | $33.0K |
| Citadel Advisors LLC | 10,836 | $32.0K |
Not filed for Q3 2021 yet (1)
Institutions that held InflaRx N.V. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| QS Investors, LLC | 174,200 | $517.0K |